共 113 条
[1]
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA 68 394-424
[2]
Ferlay J(2018)Hepatocellular carcinoma Lancet 391 1301-1314
[3]
Soerjomataram I(2018)Management, outcomes, and prognostic factors of ruptured hepatocellular carcinoma: a systematic review J Surg Oncol 117 341-353
[4]
Forner A(2017)Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis J Hepatol 67 92-99
[5]
Reig M(2015)Transarterial chemoembolization: modalities, indication, and patient selection J Hepatol 62 1187-1195
[6]
Bruix J(2005)The value and limitation of transcatheter arterial chemoembolization in preventing recurrence of resected hepatocellular carcinoma World J Gastroenterol 11 3644-3646
[7]
Moris D(2014)Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis Radiology 273 746-758
[8]
Chakedis J(2018)Added value of diffusion-weighted imaging in hepatic tumors and its impact on patient management Cancer Imaging 18 10-71
[9]
Sun SH(2016)Diffusion weighted magnetic resonance imaging in assessment of hepatocellular carcinoma after chemoembolization Egypt J Radiol Nucl Med 47 61-368
[10]
Sapisochin G(2014)Response to transcatheter arterial chemoembolization in hepatocellular carcinoma using apparent diffusion coefficient Chin J Med Imaging 22 365-815